CoreAge Rx Expands Access to Weight Loss Solutions with Compounded GLP-1 Medications
United States, 20th Nov 2025 — CoreAge Rx, a leading telehealth pharmacy dedicated to providing personalized and accessible medication solutions, today announced the expanded availability of compounded tirzepatide and semaglutide for patients seeking safe and effective weight management options. This development comes at a time of heightened nationwide demand for GLP-1 receptor agonist medications, as many individuals continue to face rising costs and supply shortages of commercially available products. GLP-1 medications—including tirzepatide and semaglutide—have become widely recognized for their clinically significant
Read more